Camellix Camellix
Camellix, based in Evans, GA, is a leader in the research and development of green tea catechins, particularly focusing on the innovative EC16 nanoparticle technology derived from epigallocatechin-3-gallate (EGCG). Their mission is to create effective health solutions targeting infectious diseases and improving overall quality of life through scientifically-backed products.
With a commitment to leveraging the natural benefits of green tea, Camellix offers a range of products aimed at addressing issues such as dry mouth, viral infections, and skin health. Their unique formulations showcase a blend of high-quality, food-grade ingredients, supported by extensive research and clinical trials to ensure safety and efficacy.
Generated from the website